Figure 3. Replication forks are compromised in response to ABL kinase inhibition or depletion in SCLC cells.

(A, C, and E) Schematic representation of the DNA fiber assays.
(B and D) DMS53 cells were treated with ABL inhibitor ABL001 (20 μM) for 24 h (B); DMS53 cells were treated with ABL inhibitor GMB475 (5 μM) for the indicated times (D); followed by sequential labeling with thymidine analogs CldU (50 μM) and IdU (100 μM) for 20 min each. Representative images (left panel) and quantification of DNA Fiber length (n = 50) (right panel). Scale bars, 5 μm. Statistics were performed with a one-way ANOVA, ****p < 0.0001, ns: not significant.
(F) DMS53 cells were transduced with either shSCR or shAA for 5 days, then sequentially labeled with thymidine analogs CldU (50 μM) and IdU (100 μM) for 20 min each. Scale bars, 5 μm. Statistics were performed with a one-way ANOVA, ****p < 0.0001.
Data in B, D, and F represented as mean +/− SEM.